The Premium Business Information Source™
Report title:
BILIM PHARMACEUTICALS-COMPANY REPORT
from
TF Market Research
28 page report published Oct 17, 2007
Price
$1,120.00
available for immediate download
This report is also available for purchase on a
per-page basis
.
Report Overview
Purchase by Section
Search Inside
About TF Market Research
...Bilim Pharmaceuticals is one of the leading generic drug s manufacturing company in Turkey and is a part of the Bilfar Holding, which also includes Kopas Cosm etics. The company was founded in #### with a mission to protect human life by enabling better treatment of the diseases and enhanc e the quality of life. Its Vision is to further expand its domestic and international market share; to strengthen its global presence in the pharmaceutical market and to maximize value for its custom ers, workers and owners. Bilim's Research & Development is dedicated to perform all formulation development tasks and projects with the most up-to- date regulatory and scientific approaches. It is highly committed to enhance products as well as applying and developing improved techniques. The company's export department operates under Business Development which is divided into two groups Licensing-In and Licensing-Out. The company offers a wide range of products namely Systemic Anti Infectives,...
Source:
LIFE SCIENCE ANALYTICS
Author:
HARINATHA, G.
Company:
BILIM PHARMACEUTICALS INC
Geographic Regions:
ASIAN CONTINENT, MIDDLE EAST, TURKEY
Format:
PDF
Sections
Title
Starting Page
Number of Pages
Company Information
1
1
Bilim Pharmaceuticals [NonUS -- Symbol : Private]
1
1
Formation Date: 1953
1
1
Business Summary
1
1
Product Glance
3
1
Diseasehub Classification
3
1
Product Summary
4
1
Condition Treated
4
3
Description
7
3
Therapeutic
7
1
Current Trial
7
6
Trial Details
7
1
Last Updated
7
1
4. Ventosal (salbutamol)
8
1
5. Zespira (montelukast)
8
1
Therapeutic
9
1
9. Asist (acetylcysteine)
9
1
Trial Details
9
6
Last Updated
9
2
12. Klamoks (amoxicillin trihydrate and potasium clavunate)
10
1
Description
11
3
Therapeutic
11
1
Drug Class
11
4
Last Updated
12
2
Therapeutic
13
3
Current Trial
14
4
Last Updated
15
1
30. Claricide (clarithromycin)
15
1
31. Klindan (clindamycin phosphate)
15
1
33. Travazol (diflucortolone valerate and isoconazole nitrate)
16
1
Description
16
1
34. Efedrin Arsan (ephedrine hydrochloride)
16
1
Trial Details
16
11
37. Gentagut (gentamycin sulphate)
17
1
Therapeutic
17
3
Drug Class
17
3
40. Spazmotek (hyoscine-N-butylbromide)
18
1
Description
18
1
Last Updated
18
1
Current Trial
19
2
44. Zeloxim (meloxicam) Fort Tablets
19
1
48. Aprol (naproxen sodium)
20
1
Description
20
1
Last Updated
20
8
49. Flaton
20
1
51. Volpan (paracetamol)
21
1
Therapeutic
21
2
52. A-Ferin (paracetamol, codeine phosphate and chlorpheniramine maleate)
21
1
Description
22
3
Current Trial
22
5
58. Pencain-K
23
1
62. Gayaben
24
1
65. Glifix (pioglitazone)
25
1
66. Metsil (simethicone)
25
1
Therapeutic
26
3
Drug Class
26
2
69. Combicid (ampicillin sodium and sulbactam sodium)
26
1
Description
26
2
73. Tobrased (tobramycin)
27
1
Current Trial
28
1
Trial Details
28
1
Date
28
1
Enter the keyword(s) which you would like to search for within this document and click "Search"
TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.
Price: $1,120.00
Questions about
this research?
Send page to a friend
Return to
Alacra Company Snapshot
Can't Decide?
Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our
FAQ
or ask our
Customer Service Team
any questions about the report you are considering purchasing.
